Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep278 | Calcium & Vitamin D metabolism | ECE2017

Primary hyperparathyroidism due to atypical adenoma: clinical, biochemical and histological features of an Italian cohort

Saponaro Federica , Giulio Marina Di , Pardi Elena , Borsari Simona , Materazzi Gabriele , Marcocci Claudio , Cetani Filomena

Primary hyperparathyroidism (PHPT) is mostly due to a benign parathyroid tumor (99%). Some have parathyroid ‘atypical adenomas’, rare tumors with histological features of parathyroid cancer (PC) (fibrous trabeculae, thick fibrous bands, mitotic figures in parenchymal cells), without local invasion or metastasis. We evaluated 20 patients with histological diagnosis of atypical adenomas. Patients were 13 women and seven males (mean age: 55±13 yrs). Nineteen patien...

ea0070aep207 | Bone and Calcium | ECE2020

18Fluoro-choline PET/CT is a useful tool for patients with primary hyperparathyroidism negative at first-line imaging localization tecniques

Apicella Matteo , Bola Stefano , Volterrani Duccio , Mazoni Laura , Frustaci Gianluca , Materazzi Gabriele , Marcocci Claudio , Cetani Filomena

Primary hyperparathyroidism (PHPT) is a common endocrine disease mainly caused by a single parathyroid adenoma. Although the localization of the parathyroid adenoma is not a surgical criteria for parathyroidectomy, this is known to increase the cure rate of PHPT and reduce the complication rate. Neck ultrasound and MIBI-scintigraphy are the first-line localization techniques to detect parathyroid adenomas, however, they have some limitations including the operator-dependent se...

ea0092ps2-17-09 | Thyroid Cancer Diagnosis 2 | ETA2023

Clinical application of grading system in sporadic medullary thyroid carcinoma patients

Prete Alessandro , Torregrossa Liborio , Gambale Carla , Materazzi Gabriele , Elisei Rossella , Matrone Antonio

Introduction: Despite its neuroendocrine origin, only recently an international study group proposed a dedicated grading system (IMTCGS) for medullary thyroid carcinoma (MTC). IMTCGS is an independent and powerful tool able to predict disease specific survival (DSS) as well as distant metastasis-free (DMFS) and locoregional recurrence-free survivals (LRFS), regardless of other risk factors, including staging.Objectives: To evaluate the performance of IMT...

ea0092ps3-27-02 | Thyroid Cancer clinical 3 | ETA2023

Central (N1A) and latero-cervical (N1B) lymph nodes metastases in sporadic medullary thyroid carcinoma patients: clinical impact on disease specific and recurrence free survival

Matrone Antonio , Prete Alessandro , Gambale Carla , Cappagli Virginia , Bottici Valeria , Materazzi Gabriele , Torregrossa Liborio , Elisei Rossella

Background: Distant metastases at diagnosis is the worst prognostic factor for disease specific survival (DSS) in sporadic medullary thyroid carcinoma (MTC). Also, lymph node metastases are negative prognostic factors both for DSS and recurrence free survival (RFS). The question whether central (N1a) and latero-cervical compartment lymph nodes metastasis (N1b), separately evaluated, can have a different impact on DSS and RFS remains to be clarified.Patie...

ea0084ps3-15-140 | Thyroid Cancer Diagnosis & Treatment | ETA2022

Basal calcitonin as guide for an early and safe thyroid surgery in RET gene carriers

Prete Alessandro , Gambale Carla , Bottici Valeria , Cappagli Virginia , Matrone Antonio , Materazzi Gabriele , Basolo Fulvio , Romei Cristina , Elisei Rossella

Introduction: Virtually all familial cases of Medullary Thyroid Carcinoma (MTC) have a RET germline mutation. Subjects harboring RET germline mutation without unaware of their condition are defined gene carriers (GC). Thyroid surgery timing is decided upon RET mutation and calcitonin levels (both basal, bCT, and stimulated, sCT). However, bCT and sCT thresholds for planning thyroid surgery have not been established, yet.Methods...

ea0070aep917 | Thyroid | ECE2020

Total thyroidectomy for amiodarone-induced thyrotoxicosis: Identification of the surgical candidates and preparation to surgery

Cappellani Daniele , Papini Piermarco , Maria Di Certo Agostino , Mantuano Michele , Manetti Luca , Materazzi Gabriele , Bartalena Luigi , Bogazzi Fausto

Background: Amiodarone-induced thyrotoxicosis (AIT) is a challenging disease associated with increased morbidity and mortality. The European Thyroid Association guidelines define the role for total thyroidectomy in the management of AIT. However, these recommendations were based on small series, which often lead to heterogeneous results and, importantly, did not identify patients who may benefit from surgery.Materials and methods: Observational longitudi...

ea0014oc5.4 | Thyroid basic | ECE2007

BRAFV600E mutations but not RET/PTC rearrangements are correlated with a lower expression of NIS mRNA expression in papillary thyroid cancer (PTC)

Romei Cristina , Piampiani Pamela , Faviana Pinuccia , Basolo Fulvio , Bottici Valeria , Sculli Mariangela , Berti Piero , Materazzi Gabriele , Pinchera Aldo , Elisei Rossella

Several studies have identified a relationship between oncogene activation and dedifferentiation of PTC. Mutations of RAS, RET/PTC and BRAF modulate the expression of thyroid genes. An impaired NIS expression has been demonstrated in PTCs harboring the BRAFV600E mutation.Aim of this study was to analyze BRAF and RET/PTC1-3 alterations and their influence on the expression of thyroid differentiation genes. Seventy-one PTC samples were studied. Quantitative analysis o...

ea0101op-06-05 | Oral Session 6: Translational thyroid cancer research | ETA2024

Molecular profiling of low-risk papillary thyroid carcinomas (MPTC) on active surveillance

Ghirri Arianna , Ramone Teresa , Prete Alessandro , Scutari Maria , Rago Teresa , Ciampi Raffaele , Romei Cristina , Materazzi Gabriele , Elisei Rossella , Molinaro Eleonora

Introduction: active surveillance (AS) is feasible and safe for low-risk papillary thyroid carcinoma with diameter ≤ 1.3 cm (mPTC), as this type of cancer shows a low percentage of progression. At the present time, there are no prognostic factors which could help to identify mPTCs at higher risk of progression. The aim of this prospective study is to find a specific molecular signature of cases that showed disease progression during AS and which would allow their early i...

ea0101ps1-05-05 | Clinical thyroid cancer research-1 | ETA2024

Impact of lymph node metastases features on presentation and outcome of patients with differentiated thyroid carcinoma (DTC)

Contartese Lea , Gambale Carla , Minaldi Elisa , Torregrossa Liborio , Molinaro Eleonora , Agate Laura , Materazzi Gabriele , Elisei Rossella , Matrone Antonio

Background: The impact of lymph node metastases (LNM) on the outcome of patients with DTC has been reevaluated in the last years. Its relevance is linked not only to the absence/presence of LNM, but also to other features such as number of LNM, dimension and extranodal extension (ENE).Aim: The aim of this study was to evaluate in a large series of patients with DTC the impact of LNM on the clinical outcome. Patients were divided according to the risk of ...

ea0101ps2-13-02 | Medullary thyroid cancer-2 | ETA2024

Basal calcitonin needs the help of stimulation test for the diagnosis of sporadic medullary thyroid cancer (MTC) only in selected cases

Faranda Alessio , Prete Alessandro , Gambale Carla , Cappagli Virginia , Bottici Valeria , Molinaro Eleonora , Materazzi Gabriele , Elisei Rossella , Matrone Antonio

Background: Calcitonin (CTN) is the main marker for the diagnosis and follow-up of patients with MTC. Its value, either basal (bCTN) or stimulated (sCTN) after calcium stimulation test (Ca-Test) is used in clinical practice for the diagnosis of patients with suspicious MTC. The aim of our study is to evaluate the performance of bCTN and sCTN in patients undergoing surgery with suspicion of sporadic MTC.Methods: We evaluated 158 consecutive patients (Jan ...